Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 121 - 135 of 602 items.
ISTODAX (romidepsin) – Restricted Access Program
AlertHealth professional risk communication | 2023-03-20
CAYSTON: Vials may be cracked in affected lots
RecallHealth product recall | 2023-03-03
Heparin Sodium Injection: Out of Specification
RecallHealth product recall | 2023-03-01
Kirkland Signature Extra Strength Acetaminophen Tablets 500 mg: Out of Specification
RecallHealth product recall | 2023-02-17
ZEJULA (niraparib) - Update on the Maintenance Treatment in Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in the Second or Later Line Setting
AlertHealth professional risk communication | 2023-02-16
AG-BISOPROLOL: Foreign matter
RecallHealth product recall | 2023-02-14
APO-AMITRIPTYLINE 10mg: NDMA Impurity
RecallHealth product recall | 2023-02-07
Celestone Soluspan: Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2023-01-31
RUZURGI (amifampridine) - Authorization Status
AlertHealth professional risk communication | 2023-01-20
Belzer MPS and Belzer UW: Particulate matter
RecallHealth product recall | 2023-01-18
NAT-Bendamustine: Discoloration
RecallHealth product recall | 2022-12-06
OCALIVA (obeticholic acid) – New Contraindication for the Treatment of Primary Biliary Cholangitis (PBC)
AlertHealth professional risk communication | 2022-12-05
Privigen: Series of adverse reactions
RecallHealth product recall | 2022-12-01
Canadian labelling for all JAK inhibitors to include risks of serious heart-related problems, fatal blood clots and cancer
AlertPublic advisory | 2022-11-01
Janus Kinase Inhibitors and the Risk of Major Adverse Cardiovascular Events, Thrombosis (Including Fatal Events) and Malignancy
AlertHealth professional risk communication | 2022-10-31